Involvement of an IgE/Mast cell/B cell amplification loop in abdominal aortic aneurysm progression

Loste, A.; Clement, M.; Delbosc, S.; Guedj, K.; Senemaud, J.; Gaston, A.-T.; Morvan, M.; Even, G.; Gautier, G.; Eggel, A.; Arock, M.; Procopio, E.; Deschildre, C.; Louedec, L.; Michel, J.-B.; Deschamps, L.; Castier, Y.; Coscas, R.; Alsac, J.-M.; Launay, P.; Caligiuri, G.; Nicoletti, A.; Le Borgne, M.

doi:10.1101/2022.09.13.507783

Home/Archive/bioRxiv

bioRxiv · 10.1101/2022.09.13.507783

Involvement of an IgE/Mast cell/B cell amplification loop in abdominal aortic aneurysm progression

View original source ↗Export metadata ↓

Abstract

AimsIgE type immunoglobulins and their specific effector cells, mast cells (MCs), are associated with abdominal aortic aneurysm (AAA) progression. In parallel, immunoglobulin-producing B cells, organised in tertiary lymphoid organs (TLOs) within the aortic wall, have also been linked to aneurysmal progression. We aimed at investigating the potential role and mechanism linking local MCs, TLO B cells, and IgE production in aneurysmal progression. Methods and ResultsThrough histological assays conducted on human surgical samples from AAA patients, we uncovered that activated MCs were enriched at sites of unhealed haematomas, due to subclinical aortic wall fissuring, in close proximity to adventitial IgE+ TLO B cells. Remarkably, in vitro the IgEs deriving from these samples enhanced MC production of IL-4, a cytokine which favors IgE class-switching and production by B cells. Finally, the role of MCs in aneurysmal progression was further analysed in vivo in ApoE-/- mice subjected to angiotensin II infusion aneurysm model, through MC-specific depletion after the establishment of dissecting aneurysms. MC-specific depletion improved intramural haematoma healing and reduced aneurysmal progression. ConclusionsOur data suggest that MC located close to aortic wall fissures are activated by adventitial TLO B cell-produced IgEs and participate to their own activation by providing support for further IgE synthesis through IL-4 production. By preventing prompt repair of aortic subclinical fissures, such a runaway MC activation loop could precipitate aneurysmal progression, suggesting that MC-targeting treatments may represent an interesting adjunctive therapy for reducing AAA progression.

Source connections

Published article ↗

Explore related subjects

pathology Preprint

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

Loste, A., Clement, M., Delbosc, S., Guedj, K., Senemaud, J., Gaston, A.-T., Morvan, M., Even, G., Gautier, G., Eggel, A., Arock, M., Procopio, E., Deschildre, C., Louedec, L., Michel, J.-B., Deschamps, L., Castier, Y., Coscas, R., Alsac, J.-M., Launay, P., Caligiuri, G., Nicoletti, A., Le Borgne, M.. 2022-09-16. Involvement of an IgE/Mast cell/B cell amplification loop in abdominal aortic aneurysm progression. https://doi.org/10.1101/2022.09.13.507783

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

NAE1-Dependent Protein Neddylation Preserves Endothelial Identity and Vascular Integrity

Background: Endothelial dysfunction is a central driver of cardiovascular and inflammatory diseases, yet the post-translational mechanisms that preserve endothelial homeostasis remain incompletely understood. Protein neddylation, the covalent conjugation of a ubiquitin-like modifier, regulates diverse cellular processes, yet its physiological role in the vascular endothelium remains unknown. This study investigated whether protein neddylation is required to preserve endothelial identity and vascular homeostasis. Methods: We generated tamoxifen-inducible endothelial-specific Nae1 knockout mice to inhibit neddylation and combined bulk RNA sequencing, single-cell and single-nucleus transcriptomics, quantitative proteomics, biochemical analyses, and gain- and loss-of-function approaches to define the role of endothelial neddylation in vascular homeostasis and inflammatory injury. Results: Endothelial-specific Nae1 deletion caused rapid mortality associated with vascular leakage, platelet accumulation, inflammation, and multi-organ injury. Multi-omics analyses demonstrated profound loss of endothelial identity, characterized by suppression of core endothelial programs and activation of inflammatory, procoagulant, and pyroptotic pathways. Single-cell analyses revealed progressive endothelial dysfunction culminating in depletion of the endothelial population and remodeling of the vascular niche. Mechanistically, endothelial neddylation deficiency activated gasdermin D (GSDMD)- and gasdermin E (GSDME)-dependent pyroptosis, whereas dual inhibition of GSDMD and GSDME markedly attenuated inflammatory transcriptomic remodeling, vascular injury, hepatocyte death, immune cell infiltration, and platelet accumulation. Translational analyses demonstrated reduced endothelial neddylation in experimental endotoxemia and decreased expression of neddylation pathway components in human atherosclerosis and COVID-19 datasets. Conversely, restoration of endothelial neddylation partially reversed inflammatory endothelial transcriptomic reprogramming in vivo. Conclusions: NAE1-dependent protein neddylation is an essential regulator of endothelial identity and vascular integrity. Loss of endothelial neddylation promotes gasdermin-dependent pyroptosis and thrombo-inflammatory vascular injury, whereas restoration of the neddylation pathway mitigates inflammatory endothelial dysfunction. These findings identify endothelial neddylation as a fundamental mechanism maintaining vascular homeostasis and a potential therapeutic target for cardiovascular and inflammatory diseases.

pathology↗

bioRxiv2024

Loss of long-chain acyl-CoA dehydrogenase protects against acute kidney injury

Proximal tubular epithelial cells (PTECs) are particularly vulnerable to acute kidney injury (AKI). While fatty acids are the preferred energy source for PTECs via fatty acid oxidation (FAO), FAO-mediated H2O2 production in mitochondria has been shown to be a major source of oxidative stress. We have previously shown that a mitochondrial flavoprotein, long-chain acyl-CoA dehydrogenase (LCAD), which catalyzes a key step in mitochondrial FAO, directly produces H2O2 in vitro. Further we have established that loss of a lysine deacylase, Sirtuin 5 (Sirt5-/-), induces hypersuccinylation and inhibition of mitochondrial FAO genes to stimulate peroxisomal FAO and to protect against AKI. However, the role of LCAD has yet to be determined. Mass spectrometry data acquisition revealed that LCAD is hypersuccinylated in Sirt5-/- kidneys after AKI. Following two distinct models of AKI, cisplatin treatment or renal ischemia/reperfusion (IRI), LCAD knockout mice (LCAD-/-) demonstrated renoprotection against AKI. Specifically, LCAD-/- kidneys displayed mitigated renal tubular injury, decreased oxidative stress, preserved mitochondrial function, enhanced peroxisomal FAO, and decreased ferroptotic cell death. LCAD deficiency confers protection against two distinct models of AKI. This suggests a therapeutically attractive mechanism whereby preserved mitochondrial respiration as well as enhanced peroxisomal FAO by loss of LCAD mediates renoprotection against AKI.

pathology↗

bioRxiv2024

Anemia and tissue hypoxia are major determinants of malarial hypelactatemia

Hyperlactatemia, a key marker of severe malaria, is closely linked to increased mortality, though the exact mechanisms remain unclear. It may result from increased lactate production due to tissue hypoxia or reduced lactate clearance from organ dysfunction. This study used Plasmodium yoelii 17XL (Py17XL) murine model of severe malaria, which closely mimics hyperlactatemia seen in human cases, to investigate the contributions of severe anemia and infection-related organ dysfunction to hyperlactatemia. Non-infectious anemia models were also included for comparison. Anemia was found to elevate lactate in both malaria-infected and non-infectious models, but Py17XL infected mice showed higher lactate levels, indicating that anemia alone doesnt fully explain hyperlactatemia. Evidence of tissue hypoxia, particularly in the liver, kidney, and gut, was seen with hypoxyprobe staining and upregulated hypoxia-inducible factor 1-alpha (HIF-1), suggesting that hypoxia drives increased glycolysis and lactate production. Impaired lactate clearance may also play a role, as infected mice showed signs of liver and kidney dysfunction accompanied by reduced clearance of 13C3-labeled sodium-L-Lactate. Whole blood transfusion combined with artesunate significantly improved lactate clearance compared to artesunate alone, underscoring the importance of addressing anemia in treatment. A link between intestinal damage and hyperlactatemia was suggested by correlations between trefoil factor 3 (TFF3), a marker of gut injury, and lactate levels in human samples. Our findings highlight the multifactorial origin of hyperlactatemia in malaria, driven primarily by anemia and tissue hypoxia, pointing to the need for therapies targeting both aspects to reduce mortality in severe cases.

pathology↗